Tami Dvash

Tami Dvash has extensive experience in the field of research and development (R&D). Tami is currently serving as the Vice President of R&D for meat products at Aleph Farms, a position they have held since February 2022. Prior to that, they worked as the Vice President of R&D at SYNERGIO from February 2021 to May 2022.

Tami's R&D experience also includes their tenure at Merck Group, where they served as the Microbiome Head of Product Development R&D from January 2019 to February 2021. Before that, they held the position of Department Head for Natural Biotechnology Systems R&D from May 2016 to January 2019.

Tami gained valuable scientific expertise during their time at Sigma-Aldrich, where they worked as a Senior Scientist in Innovative Technology & ADME/Tox R&D from September 2014 to May 2016. Prior to that, they held the role of Senior Scientist in Stem Cell Research from November 2010 to August 2014.

Tami's academic background includes a PhD from The Hebrew University of Jerusalem, where they completed their studies at Prof. Nissim Benvenisty Lab on Molecular Analysis of Human Embryonic Stem Cells as a Model for Early Human Development from September 2002 to September 2007. Tami also served as a Teaching Assistant during their time at the university.

Earlier in their career, Tami worked as a Postdoctoral Fellow in Stem Cell Research at UCLA from August 2007 to December 2010.

Overall, Tami Dvash has a diverse and impressive work experience in research and development, particularly in areas related to microbiome, natural biotechnology systems, innovative technology, and stem cell research.

Tami Dvash has an extensive education history spanning from 1997 to 2007. Tami began their academic journey at The Hebrew University of Jerusalem, where they obtained a Bachelor of Science in Medical Sciences from 1997 to 2000. After completing their undergraduate degree, they pursued further studies at the same institution, earning a Master of Science degree in Genetics of Complex Traits from 2000 to 2002. Continuing their academic pursuits, Tami went on to attain a PhD from The Hebrew University of Jerusalem from 2002 to 2007, specializing in Human Embryonic Stem Cells.